Status:
UNKNOWN
Telomere Biology in Early Adenocarcinoma of the Lung
Lead Sponsor:
Meir Medical Center
Conditions:
Adenocarcinoma of the Lung
Adenocarcinoma, Bronchiolo-Alveolar
Eligibility:
All Genders
18-90 years
Brief Summary
Early adenocarcinoma of the lung has an excellent five-year survival after resection. However, its clinical and radiologic presentation is highly variable. Traditional means for preoperative diagnosis...
Detailed Description
Bronchoalveolar carcinoma has been traditionally used to refer to a subset of adenocarcinoma distinguished by its peripheral location, typical "lepidic" growth pattern and tendency for both bronchogen...
Eligibility Criteria
Inclusion
- Patients referred by a multi-disciplinary team meeting recommendation for surgical lung biopsy due to suspected adenocarcinoma of the lung and agree to a one-time peripheral blood sample for telomere analysis as described.
Exclusion
- Patients whom were not evaluated by the multi-disciplinary team discussion prior to referral for surgical lung biopsy.
- Patients with other chronic inflammatory disease requiring immunosuppressive therapy or known extra-pulmonary malignancy.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02239432
Start Date
September 1 2014
End Date
September 1 2017
Last Update
September 12 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka University Medical Center
Beersheba, Israel, 84101
2
Meir Medical Center
Kfar Saba, Israel, 4428164